Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment
Clinical trial NCT00016237 · COMPLETED
Trial details
- NCT number
- NCT00016237
- Sponsor
- EMD Serono
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.